title: Multidisciplinary management of malignant pleural effusion.
abstract: Approximately 50% of patients with metastatic disease develop a malignant pleural effusion (MPE). Prompt clinical evaluation and treatment to achieve successful palliation are the main goals of management of MPE. Optimal treatment is still controversial and there is no universal standard approach. Management options include observation, thoracentesis, indwelling pleural catheter (IPC) or chest tube placement, pleurodesis, and surgical pleurectomy. The treatment for each patient should be based on symptoms, general condition, and life expectancy.
authors.affiliation: Section of Surgical Oncology, Department of Surgery, Penn State Hershey Cancer Institute, Penn State College of Medicine, Hershey, Pennsylvania, USA. jkaifi@hmc.psu.edu
authors.forename: Jussuf T
authors.initials: JT
authors.lastname: Kaifi
authors.forename: Jennifer W
authors.initials: JW
authors.lastname: Toth
authors.forename: Niraj J
authors.initials: NJ
authors.lastname: Gusani
authors.forename: Eric T
authors.initials: ET
authors.lastname: Kimchi
authors.forename: Kevin F
authors.initials: KF
authors.lastname: Staveley-O'Carroll
authors.forename: Chandra P
authors.initials: CP
authors.lastname: Belani
authors.forename: Michael F
authors.initials: MF
authors.lastname: Reed
mesh_terms: D003131:Combined Modality Therapy; D006801:Humans; D016066:Pleural Effusion, Malignant / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D012597:Sclerosing Solutions / Q000627:therapeutic use; D020775:Thoracic Surgery, Video-Assisted; D013906:Thoracoscopy
chemical_list: D012597:Sclerosing Solutions